1. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level. (2nd September 2020) Authors: Aggarwal, R; Moghadam-Kia, S; Lacomis, D; Malik, A; Qi, Z; Koontz, D; Burlingame, RW; Oddis, CV Journal: Scandinavian journal of rheumatology Issue: Volume 49:Number 5(2020) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗